Literature DB >> 35274148

Selective serotonin reuptake inhibitors use and the risk of hepatocellular carcinoma: a systematic review and dose-response analysis of cohort studies with one million participants.

Akshaya Srikanth Bhagavathula1, Benjamin Woolf2, Jamal Rahmani3, Kota Vidyasagar4, Wubshet Tesfaye5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35274148     DOI： 10.1007/s00228-022-03309-y

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  2 in total

Review 1.  A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Authors:  Ju Dong Yang; Pierre Hainaut; Gregory J Gores; Amina Amadou; Amelie Plymoth; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08-22       Impact factor: 73.082

2.  Hepatocellular carcinoma and antidepressants: a nationwide population-based study.

Authors:  Vincent Chin-Hung Chen; Chiao-Fan Lin; Yi-Hsuan Hsieh; Hsin-Yi Liang; Kuo-You Huang; Wei-Che Chiu; Yena Lee; Roger S McIntyre; Hsiang-Lin Chan
Journal:  Oncotarget       Date:  2017-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.